26Sep 2023
Skin cancer risk of menopausal hormone therapy

Skin cancer risk of menopausal hormone therapy

A retrospective cohort study found that menopausal hormone therapy (MHT) was not associated with an increased risk of melanoma in menopausal Korean women. However, tibolone and combined estrogen plus progestin by the manufacturer (COPM) were associated with a reduced risk of non-melanoma skin cancer (NMSC), while other hormone groups showed no significant effect on NMSC risk.

  • #dermatology

Like

Save

Share